CytomX Therapeutics

AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
Fierce Biotech
Tue, 03/28/23 - 10:22 am
AbbVie
CytomX Therapeutics
cancer
oncology
antibody-drug conjugate
Regeneron, CytomX Ink Potentially $2B Bispecific Immunotherapy Deal
BioSpace
Thu, 11/17/22 - 12:05 pm
Regeneron
CytomX Therapeutics
bispecifics
cancer
Veloci-Bi
drug development
CytomX slashes headcount by 40% after breast cancer setback, with later-stage development bearing the brunt
Fierce Biotech
Thu, 07/14/22 - 10:58 am
CytomX Therapeutics
breast cancer
layoffs
praluzatamab ravtansine
CytomX R&D day reveals Probody toxicity, chopped BMS deal
BioCentury
Tue, 02/26/19 - 06:32 pm
CytomX Therapeutics
CD166
Bristol-Myers Squibb
probodies
Biotech IPOs Slow to a Trickle as Stock Rout Unnerves Investors
Bloomberg
Thu, 10/8/15 - 09:31 am
biotech
IPOs
CytomX Therapeutics